Celanese Corporation Reports First Quarter Earnings
Celanese reported Q1 2026 net sales of $2.34 billion, down 2% year-over-year but up 6% sequentially, with adjusted EPS of $0.85. Management raised full-year free cash flow guidance to $700-$800 million and projected strong Q2 adjusted EPS of $2.00-$2.40, driven by improved pricing and volume in the Acetyl Chain.
Key figures
- Eps
- 0.85
- Revenue
- 2337000000
- Guidance
- Q2 2026 adjusted EPS $2.00-$2.40; FY 2026 free cash flow $700-$800 million; H2 2026 adjusted EPS ~$3.00
- Revenue Yoy
- -2%
- Fcf
- 3000000
- Adjusted ebit
- 275000000
- Operating ebitda
- 455000000
- Operating income
- 214000000
- Net debt to ebitda guidance
- 4.8x
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.